| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Wigzell Hans Lennart Rudolf is a Director at Sarepta Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $503K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 10,500 | $124.84 | $1,310,820.00 | -31.5% | -19.8% | -82.7% | |
| Mar 8, 2024 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 15,000 | $123.25 | $1,848,795.25 | -15.7% | -5.6% | -17.2% | |
| Aug 4, 2023 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 15,000 | $106.72 | $1,600,800.00 | -41.7% | -26.2% | +36.7% | |
| Mar 8, 2021 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 10,000 | $83.51 | $835,100.00 | -37.7% | - | - | |
| Aug 10, 2020 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 10,000 | $159.00 | $1,590,043.90 | -26.1% | - | - | |
| May 20, 2020 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 5,000 | $150.64 | $753,209.70 | -10.0% | - | - | |
| Mar 4, 2020 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 5,000 | $116.89 | $584,450.00 | -26.6% | - | - | |
| May 23, 2019 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 10,000 | $120.00 | $1,200,000.00 | -46.0% | - | - | |
| Nov 1, 2018 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 6,667 | $140.50 | $936,713.50 | -39.8% | - | - | |
| Nov 30, 2017 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 6,667 | $55.89 | $372,618.63 | -50.0% | - | - |